Hemispherx Biopharma (HEB) Reports Q3 Loss of $0.30/Share
Tweet
Share
E-mailGet Alerts HEB Hot Sheet
Price: $1.80 --0%
Financial Fact:
Basic and diluted loss per share (Note 2): -0.01
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Basic and diluted loss per share (Note 2): -0.01
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Hemispherx Biopharma (NYSE: HEB) reported Q3 EPS of ($0.30), versus ($0.62) reported last year.
For earnings history and earnings-related data on Hemispherx Biopharma (HEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
